Mission Statement

Dyne Immune is committed to improving human health and quality of life worldwide by preventing the spread of infectious disease. Dyne Immune dedicates its resources to the research and development of portable, affordable, non-instrument pathogenic diagnostic tools for use in the field and in the laboratory, and to making these tools accessible to those who can benefit from them the most.

V. James deFranco, MD, CEO Dyne Immune, LLC.
Dr. deFranco received dual undergraduate degrees in biology and chemistry from Xavier University in Cincinnati Ohio and his MD degree from the Saint Louis University, School of Medicine. He served his Internship & Residency at Good Samaritan Hospital in Cincinnati, Ohio specializing in Pediatrics where he was the first to recover Rh-negative antibodies used to prevent Hemolytic Disease of the new born. He was also instrumental in designing protocols for preventing hospital nosocomial infections in new born nurseries. After residency, Dr. DeFranco served as Chief of Pediatrics Alaskan Air Command, United States Air Force Hospital, Anchorage, Alaska. He was also consultant to the Surgeon General for Alaska Air Command, Washington DC. He then moved to a private clinical practice in Cincinnati, Ohio, while simultaneously conducting independent Bio-Pharmaceutical research and consulting to major pharmaceutical companies. Throughout his medical career Dr. deFranco has been a co-investigator for over 40 FDA approved phase II and phase III protocols involving allergy and neurodegenerative diseases. Currently he is serving as CEO and Director of Translational Medicine and Early Detection Initiative at Dyne Immune and as a member of the Scientific Advisory Board for a leader in Liposome drug delivery systems.

Michael Hutchital, PHD - Chief Scientific Officer
Dr. Hutchital earned his Doctoral Degree at the Graduate School and University Center of the City University of New York. Dr. Hutchital has developed over 100 Immunoassays for the early rapid on site detection of infectious diseases, bio-toxins, agricultural contaminants and industrial wastes.  He also serves as a visiting professor at Mount Saint Mary College in New York as instructor of Molecular Genetics, Immunology and Microbiology.

Ron Lewkiewicz - Director of IT Dyne Immune, LLC.
Ron Lewkiewicz has over 40 years of experience in the IT field including experience with mainframes, servers, networks, security, and all associated peripheral hardware and software. After serving as a paratrooper in the 101st Airborne Division directly after high school, he earned a BS degree from RCA Institute of Technology in Electrical Engineering and immediately joined IBM as a mainframe engineer. Six years later, he transferred to the IBM facility in San Jose, CA where he worked in the R&D labs as a microcode engineer for 16 years. Since then he has worked as director of IT for two different start-up companies as well as contract work for several other corporations.

A Message From Dr. DeFranco, CEO

Dear Reader,
Over the last 100 years, medical science has vastly improved our ability to defend from illness, reduce suffering, and increase life expectancy. Unfortunately, too many people continue to be exposed to dangerous infections and suffer from illness due to inadequate diagnostic technology.

Early detection saves lives

Health care professionals need access to the diagnostic tools that can detect infection quickly, allowing them to initiate appropriate treatment and reduce the risk of exposure for others. Early detection can stop the spread of infection and save lives.

Dyne Immune was established in order to help health care professionals do just that.

Technology solutions for real life

We create portable, affordable technology that enables professionals to quickly and easily screen for specific pathogens. Dyne Immune RAPID™ Screens provide everything needed for testing in a compact kit that can be used in the lab or in the field – and deliver results in about 30 minutes.

Using our Rabies RAPID™ Screen, for example, veterinarians and animal control workers can determine within minutes if a particular dog or cat is infected with the deadly rabies virus.

Traditional rabies testing requires euthanasia of the animal in question, and results can take costly days or weeks. But with just a swab of saliva and the Rabies RAPID™ Screen kit, hundreds of animals - and the people who care for them- can be protected from exposure.

Join us in making a difference

Dyne Immune LLC is dedicated to improving quality of life and promoting health globally, through the detection and prevention of infectious disease. We specialize in non-instrument based, on-site affordable testing technology that empowers health care workers to make crucial decisions, sooner.

RAPID™ Screens currently in development include tests for rabies, polio, pneumonia and tularemia. You may also contact us with your requests for customized RAPID™ Screens.

And, so that you can get to know Dyne Immune a little bit better, we are inviting qualified professionals to try out and evaluate a Rabies RAPID™ Screen, at the discounted price of $50.00 plus $20.00 shipping and handling on each order.

Wishing you a safe and healthy season,

Dr. Jim DeFranco
Dyne Immune CEO